Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
Table of Contents Introduction: 1 Bangladeshi Pharmaceutical Industry: 2 Industry Analysis: 2 Competitive Force 1: Rivalry among Existing Firms 3 Competitive Force 2: Threat of New Entrants 3 Competitive Force 3: Threat of Substitute Products 3 Competitive Force 4: Bargaining Power of Buyers 4 Competitive Force 5: Bargaining Power of Suppliers 4 Competitive Strategy Analysis: 5 Cost Leadership: 5 Product Differentiation: 5 Corporate Strategy Analysis: 6 Conclusion:………………………………………………………………………………………………………7
Premium Generic drug Pharmacology Pharmaceutical industry
Knowledge Management in the Pharmaceutical Industry Introduction The study of Knowledge Management is a process that has been researched for centuries by western philosophers and traditional theorists‚ however it is only until recently that knowledge management has been the main focus for many organisations. Many have said that it was the publishing of Karl Wiig’s‚ “knowledge management foundations” (1993)‚ that sparked the huge interest in knowledge management and nearly two decades on KM is
Premium Knowledge management Pharmacy
includes an external environmental analysis of Brazil’s pharmaceutical industry. The current pharmaceutical industry is still in its developing stage because the majority of pharmacological therapies made available to the public are either free or heavily subsidized by the government. The industry is also affected by a number of new regulations such as the National Drug Control System and Registration requirements for Active Pharmaceutical Ingredients (APIs) in November 2009‚ and new labelling &
Premium Pharmacology Medicine Economics
EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
Introduction: The Reliable Pharmaceutical Service is a privately held company incorporated in 1975 in Albuquerque‚ New Mexico. It provides pharmacy services to health-care delivery organizations that are too small to have their own in-house pharmacy. The Reliable pharmaceutical industry (RPS) has been doing well but with the coming of new technology and software implementation RPS has lost its effective business. Order-entry‚ billing‚ and inventory-management procedures are a hodgepodge of manual
Premium Pharmacology Pharmacy Pharmaceutical drug
State intervention in the pharmaceutical industry: social advance or threat to innovation? By Ivan Topalovic Introduction 1/ The Product A/ European level‚ the “EMEA” B/ R.O.W. a) The Followers b) The non-Followers 2/ The Price A/ Worldwide parameters B/ Examples of price fixing per country 3/ The Place 4/ The Promotion Conclusion Appendix I Chronology in therapeutic innovation Appendix II Major pharmaceutical companies mergers / acquisitions
Premium Pharmacology Clinical trial Generic drug
Alliance Concrete Case Questions Each team should prepare a written report (2 to 3 pages) on this case. Please ensure you answer the following questions in your report. Note that question 1 requires you to do a financial projection of Alliance Concrete’s 2006 financial statements (using Excel). One team will be selected at random to lead the class discussion on the case and present their 2006 financial projections. 1. What is your best estimate of the 2006 financial statements? As a starting
Premium Finance Debt Bond
YRH: Pharmaceutical Industry in China to 2020 Market Overview‚ Size‚ Share‚ Analysis‚ Technology Developments‚ Development Status‚ Trends‚ Structure‚ Production Value and Forecast Research Report Summary “Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies‚ Industry Trends‚ Environment‚ Regulation‚ Market Drivers‚ Restraints‚ Opportunities & Challengess” provides a detailed investigation of the market size‚ segmentation‚ key players‚ SWOT
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
| Ethics in Corporate Society | | PHARMACEUTICAL MARKETING-the growing ethical concern? Analytical Report | | | Madiha Raza Noama Naeem Sheikh Zargham Zaigham LETTER OF AUTHORIZATION November 5‚ 2011 Dear Readers‚ As students of BBA‚ our course instructor of Ethics in Corporate Society‚ Ms. Tania Danish authorized us to make a report on the “PHARMACEUTICAL MARKETING-the growing ethical concern?” We were required to make a report in accordance to our learning in the course
Premium Pharmacology Pharmaceutical industry Pharmacy